We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 3,398 results
  1. Contrast-Induced Nephropathy (CIN) and Biomarkers

    Acute kidney injury (AKI) is a sudden loss of kidney function secondary to a variety of reasons. Contrast-induced nephropathy (CIN) is a form of AKI...
    Georgios Georgiadis, Anca Oana Docea, ... Charalampos Mamoulakis in Biomarkers in Toxicology
    Reference work entry 2023
  2. Contrast-Induced Nephropathy (CIN) and Biomarkers

    Acute kidney injury (AKI) is a sudden loss of kidney function secondary to a variety of reasons. Contrast-induced nephropathy (CIN) is a form of AKI...
    Georgios Georgiadis, Anca Oana Docea, ... Charalampos Mamoulakis in Biomarkers in Toxicology
    Living reference work entry 2022
  3. Contrast-induced nephropathy and oxidative stress: mechanistic insights for better interventional approaches

    Contrast-induced nephropathy (CIN) or contrast-induced acute kidney injury (CI-AKI) is an iatrogenic acute kidney injury observed after intravascular...

    Prit Kusirisin, Siriporn C. Chattipakorn, Nipon Chattipakorn in Journal of Translational Medicine
    Article Open access 20 October 2020
  4. Insights into the Therapeutic Potential of Phytoconstituents as an Epigenetic Modulators in Diabetic Nephropathy

    Chronic diabetes is commonly associated with the development of nephropathy, which is a prevalent complication. Hyperglycemia is believed to initiate...

    Komal Thapa, Heena Khan, ... Thakur Gurjeet Singh in Current Pharmacology Reports
    Article 26 October 2023
  5. Multiple myeloma with acute light chain cast nephropathy

    Light chain cast nephropathy (LCCN) is a leading cause of acute kidney injury (AKI) in patients with multiple myeloma (MM) and is now defined as a...

    Nelson Leung, S. Vincent Rajkumar in Blood Cancer Journal
    Article Open access 29 March 2023
  6. Prevention of contrast induced-acute kidney injury using coenzyme Q10 in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention

    Purpose

    We assessed the potential effect of CoQ10 administration for the prevention of contrast induced-acute kidney injury (CI-AKI) in patients with...

    Davoud Ahmadimoghaddam, Seyed Saman Talebi, ... Maryam Mehrpooya in European Journal of Clinical Pharmacology
    Article 01 August 2023
  7. Nicotine exacerbates diabetic nephropathy through upregulation of Grem1 expression

    Background

    Diabetic nephropathy (DN) is a major complication of diabetes mellitus. Clinical reports indicate that smoking is a significant risk factor...

    Jianning Chen, Haiting **ao, ... Pravin Singhal in Molecular Medicine
    Article Open access 06 July 2023
  8. Identification of co-expressed central genes and transcription factors in acute myocardial infarction and diabetic nephropathy

    Background

    Acute myocardial infarction (AMI) and diabetic nephropathy (DN) are common clinical co-morbidities, but they are challenging to manage and...

    Bo Li, Xu Zhao, ... Yan Ding in BMC Medical Genomics
    Article Open access 20 May 2024
  9. Renal angiotensin I-converting enzyme-deficient mice are protected against aristolochic acid nephropathy

    The renal renin-angiotensin system (RAS) is involved in the development of chronic kidney disease. Here, we investigated whether mice with reduced...

    Annett Juretzko, Antje Steinbach, ... Rainer Rettig in Pflügers Archiv - European Journal of Physiology
    Article Open access 15 December 2022
  10. Wogonin upregulates SOCS3 to alleviate the injury in Diabetic Nephropathy by inhibiting TLR4-mediated JAK/STAT/AIM2 signaling pathway

    Background

    Diabetic nephropathy (DN) is a life-threatening renal disease and needs urgent therapies. Wogonin is renoprotective in DN. This study aimed...

    Yufeng Liu, Mengbi Zhang, ... **aoyan Su in Molecular Medicine
    Article Open access 06 June 2024
  11. Sestrin2 attenuates renal damage by regulating Hippo pathway in diabetic nephropathy

    Glomerular mesangial cell proliferation and extracellular matrix accumulation contribute to the progression of diabetic nephropathy (DN). As a...

    Yawei Bian, Chonglin Shi, ... Yonghong Shi in Cell and Tissue Research
    Article 12 July 2022
  12. Tanshinone IIA is superior to paricalcitol in ameliorating tubulointerstitial fibrosis through regulation of VDR/Wnt/β-catenin pathway in rats with diabetic nephropathy

    Glomerulosclerosis and tubulointerstitial fibrosis (TIF) are closely involved in the development of diabetic nephropathy (DN). Moreover, the...

    **g-Yi Zeng, Yu Wang, ... **ao-Rong Bao in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article Open access 22 November 2023
  13. Omics are Getting Us Closer to Understanding IgA Nephropathy

    During the last decade, thanks to omics technologies, new light has been shed on the pathogenesis of many diseases. Genomics, epigenomics,...

    Krzysztof Mucha, Michał Pac, Leszek Pączek in Archivum Immunologiae et Therapiae Experimentalis
    Article Open access 15 April 2023
  14. Histone modification in podocyte injury of diabetic nephropathy

    Diabetic nephropathy (DN), an important complication of diabetic microvascular disease, is one of the leading causes of end-stage renal disease...

    Simeng Wang, **nyu Zhang, ... Rong Wang in Journal of Molecular Medicine
    Article 30 August 2022
  15. Imbalance of T follicular helper cell subsets trigger the differentiation of pathogenic B cells in idiopathic membranous nephropathy

    Objective

    This study aims to elucidate the role of T follicular helper (Tfh) cells and their subsets in idiopathic membranous nephropathy (IMN).

    ...
    Bishun Deng, Huijie Huang, ... Min He in Inflammation Research
    Article 11 March 2024
  16. Modeling of Fabry disease nephropathy using patient derived human induced pluripotent stem cells and kidney organoid system

    Objectives

    To explore the possibility of kidney organoids generated using patient derived human induced pluripotent stem cells (hiPSC) for modeling of...

    Sheng Cui, **anying Fang, ... Byung Ha Chung in Journal of Translational Medicine
    Article Open access 22 February 2023
  17. Fibroblast growth factor 21 attenuates salt-sensitive hypertension-induced nephropathy through anti-inflammation and anti-oxidation mechanism

    Background

    Patients with salt-sensitive hypertension are often accompanied with severe renal damage and accelerate to end-stage renal disease, which...

    Hua-Chun Weng, **n-Yu Lu, ... Hong-Wei Wang in Molecular Medicine
    Article Open access 13 November 2021
  18. Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathy

    IgA nephropathy (IgAN) is a progressive form of kidney disease defined by glomerular deposition of IgA. Here we performed a genome-wide association...

    Krzysztof Kiryluk, Elena Sanchez-Rodriguez, ... Ali G. Gharavi in Nature Genetics
    Article 19 June 2023
  19. Probiotics ameliorate IgA nephropathy by improving gut dysbiosis and blunting NLRP3 signaling

    Background

    Recently, a few studies have indicated a relationship between the gut microbiota and IgA nephropathy (IgAN). Whether the gut microbiota...

    Jiaxing Tan, Lingqiu Dong, ... Wei Qin in Journal of Translational Medicine
    Article Open access 29 August 2022
  20. Evaluation of coenzyme Q10 combined with or without N-acetyl cysteine or atorvastatin for preventing contrast-induced kidney injury in diabetic rats

    Combined antioxidants effect for prevention of contrast-induced nephropathy (CIN) remains unclear. This study assessed the potential protective...

    Osama Y. Alshogran, Shreen D. Nusair, ... Maya Sweidan in Naunyn-Schmiedeberg's Archives of Pharmacology
    Article 25 February 2021
Did you find what you were looking for? Share feedback.